Key result
Discontinuation of the triggering anesthetic agent and active cooling successfully resolved suspected malignant hyperthermia in a 20-year-old male without the use of dantrolene.
Population
1 young male patient undergoing axillary osmidrosis surgery
Design
Case_report
Authors
Loading...
Alerts clinicians to MH risk during anesthesia; case report leaves open optimal susceptibility screening strategies.
Case Report (n=1)
No
This case report highlights the rare but potentially lethal occurrence of malignant hyperthermia during surgery, emphasizing the need for immediate recognition and treatment.
Kim et al. (2022) conducted a case report in Malignant hyperthermia (n=1). Discontinuation of triggering agents and active cooling was evaluated on Clinical recovery from malignant hyperthermia crisis. Discontinuation of the triggering anesthetic agent and active cooling successfully resolved suspected malignant hyperthermia in a 20-year-old male without the use of dantrolene.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: